$NRXP - NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-announces-123000060.html